A new checkpoint in lupus - 04/04/19
Doi : 10.1016/j.jaci.2018.12.996
George C. Tsokos, MD ⁎ 
Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Mass
∗Corresponding author: George C. Tsokos, MD, Department of Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, 330 Brookline Ave, Boston, MA 02215.Department of MedicineBeth Israel Deaconess Medical CenterHarvard Medical School330 Brookline AveBostonMA02215
Key words : Autoantibodies, lupus, checkpoint control, autoimmunity
Le texte complet de cet article est disponible en PDF.
| Disclosure of potential conflict of interest: G. C. Tsokos serves on the Scientific Advisory Boards of ABPRO and Silicon Therapeutics, has received grants from the National Institutes of Health, and is an employee of Harvard Medical Faculty Associates. |
© 2019
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 143 - N° 4
P. 1351-1352 - avril 2019 Retour au numéro
Article précédent
- Macrophage polarization: Reaching across the aisle?
- Maria Carla Bosco
- Systemic antibody responses to gut commensal bacteria: How and why do I know you?
- Peter J. Mannon
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?